Tetrazine-Ph-PEG5-NHS ester
Code | Size | Price |
---|
TAR-T17063-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T17063-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
Tetrazine-Ph-PEG5-NHS ester is a PEGylated N-hydroxysuccinimide (NHS) ester molecule that serves as a linker in the synthesis of proteolysis targeting chimeras (PROTACs)[1].
CAS:
1682653-80-0
Formula:
C27H36N6O10
Molecular Weight:
604.61
Purity:
0.98
SMILES:
O=C(ON1C(=O)CCC1=O)CCOCCOCCOCCOCCOCCC(=O)NCC2=CC=C(C=C2)C=3N=NC=NN3
References
An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562